Related Experiment Videos
Genetic networks controlling retinal injury
Felix R Vazquez-Chona1, Amna N Khan, Chun K Chan
1Department of Ophthalmology, The Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USA. fvazquez@utmem.edu
Molecular Vision
|November 17, 2005
Summary
This study identifies genetic regions controlling gene expression after retinal injury. It pinpoints the inhibitor of DNA binding 2 (Id2) as a key regulator in the acute phase response.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- The acute phase response involves coordinated gene expression changes in response to injury.
- Understanding the genetic regulation of this response is crucial for developing therapeutic strategies.
Purpose of the Study:
- To define genomic loci responsible for coordinated gene expression changes following retinal injury.
- To identify upstream regulators controlling acute phase gene expression.
Main Methods:
- Combined microarray data from rat retina, brain, and spinal cord injury studies.
- Utilized BXD recombinant inbred mouse strains for genetic linkage analysis.
- Employed SNP and promoter motif databases to identify candidate regulators.
Main Results:
- Identified three genomic loci controlling acute phase gene expression in the brain.
- Discovered a significant locus on chromosome 12 associated with classic acute phase genes.
- Identified inhibitor of DNA binding 2 (Id2) as a candidate upstream regulator, upregulated in injury models.
Conclusions:
- Defined transcriptional changes associated with acute retinal injury.
- Identified regulatory loci and candidate regulators, including Id2, controlling acute phase gene expression via genetic analysis.